Product Description: STX-478 (compound 80) is an oral CNS-penetrant allosteric mutant-selective PI3Kα inhibitor. STX-478 shows robust and durable tumor regression and can be used in cancer research[1].
Applications: Cancer-Kinase/protease
Formula: C16H12F5N5O2
References: [1]JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1.